Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Genetic Services Laboratory University of Chicago United States | 9 | 13 |
|
Genetics and Molecular Pathology SA Pathology Australia | 3 | 1 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
FTL - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Invitae Neurodegeneration with Brain Iron Accumulation Panel Invitae United States | 41 | 20 |
|
Invitae Comprehensive Neurometabolic Disorders Panel Invitae United States | 351 | 249 |
|
Invitae Iron Related Disorders Panel Invitae United States | 39 | 27 |
|
Invitae Cerebral Palsy Spectrum Disorders Panel Invitae United States | 638 | 419 |
|
Invitae Brain Malformations Panel Invitae United States | 247 | 161 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Parkinson Disease and Parkinsonism Panel PreventionGenetics United States | 68 | 70 |
|
Neurodegeneration with Brain Iron Accumulation and Infantile Neuroaxonal Dystrophy Panel PreventionGenetics United States | 18 | 16 |
|
Cataract panel. NGS panel of 69 genes. Genologica Medica Spain | 146 | 69 |
|
Neurodegeneration with Brain Iron Accumulation (NGS Panel and Copy Number Analysis) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 9 | 11 |
|
Congenital Cataracts NGS Panel Fulgent Genetics United States | 106 | 56 |
|
Hyperferritinemia-Cataract Syndrome (FTL Single Gene Test) Fulgent Genetics United States | 3 | 1 |
|
Neuroferritinopathy (FTL Single Gene Test) Fulgent Genetics United States | 3 | 1 |
|
Brain-Iron Accumulation NGS Panel Fulgent Genetics United States | 36 | 13 |
|
Neurodegeneration with Brain Iron Accumulation Disorders: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 9 | 8 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.